Buy this Article for $10.95

Have a coupon or promotional code? Enter it here:

When you buy this you'll get access to the ePub version, a downloadable PDF, and the ability to print the full article.


hemorrhage, hemorrhagic shock, tranexamic acid, trauma, TXA



  1. Gaines-Dillard, Nancy DNP, MSN, APRN-BC
  2. Bartley, Marilynn K. MSN, FNP-BC
  3. Rosini, Jamie M. PharmD, BCPS, BCCP


Abstract: Tranexamic acid (TXA) is an antifibrinolytic agent that has been shown to decrease mortality in trauma patients at risk for or actively bleeding. This article discusses the risks and benefits of using I.V. TXA to treat patients with traumatic injuries and critical assessment considerations for critical care nurses caring for patients who may be candidates for this therapy.